Search hospitals > California > Modesto
Kaiser Permanente-Modesto
Claim this profileModesto, California 95356
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
134 reported clinical trials
6 medical researchers
Summary
Kaiser Permanente-Modesto is a medical facility located in Modesto, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Kaiser Permanente-Modesto is involved with conducting 134 clinical trials across 302 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Natalya Greyz-Yusupov.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Jennifer M. SugaKaiser Permanente-Oakland1 year of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
34 reported clinical trials
98 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara2 years of reported clinical research
Studies Cancer
Studies Breast Cancer
22 reported clinical trials
63 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo7 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
21 reported clinical trials
51 drugs studied
Natalya Greyz-YusupovKaiser Permanente-Fresno4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
11 drugs studied
Clinical Trials running at Kaiser Permanente-Modesto
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Cutaneous Melanoma
Squamous Cell Carcinoma
Melanoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente-Modesto?
Kaiser Permanente-Modesto is a medical facility located in Modesto, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Kaiser Permanente-Modesto is involved with conducting 134 clinical trials across 302 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Natalya Greyz-Yusupov.